. (open access) shows that athletes of the mind � chess grandmasters � show the same longevity advantage as athletes of the body.
.
rewards
-
.
- .: "arise: a phase 3 randomized trial of erenumab for episodic migraine." .
- eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
$17
OFF DEAL
OFF DEAL
GET DEAL
218 Used Today
50%
OFF DEAL
OFF DEAL
GET DEAL
181 Used Today